ICON PLC at Goldman Sachs Global Healthcare Conference Transcript
All right. Good morning, everyone. Welcome to the ICON session. I'm Bob Jones, and I cover the CRO industry here at Goldman Sachs. Very pleased to have ICON, a leading clinical CRO up on stage with us today. Representing the company, I'm joined by Dr. Steve Cutler, who has been CEO of ICON since March of 2017, previously had been the COO from January 2014, prior to this, he served as the Group President of Clinical Research Services, I believe, since 2011. So definitely, has been with the company for a number of years now and really excited to have him with us.
The format, I think, by this point, everyone is aware to the extent that you have a question, please feel free to raise your hand and we'll be sure to get you a microphone.
Questions & Answers
I guess, Dr. Cutler, just to start, over the past 2 to 3 years, it seems like a lot of the larger, global CROs have made an attempt mainly through
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |